20/09/2017
Auris Medical to Present at the LEERINK Partners Rare Disease Roundtable Series on September 27
Auris Medical Holding AG(NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology, today announced thatThomas Meyer, Ph.D., Chairman [...]
